Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVANHOE: Impact of Rotavirus Vaccination on Gastroenteritis Hospitalization
NCT00740935Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- May 2007
- Primary completion
- Dec 2010
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rotavirus vaccine, live, oral, pentavalent in rotavirus gastroenteritis, sponsored by Centre Hospitalier Universitaire de Brest. Primary endpoint: Hospitalization for gastroenteritis at 2 years. Started May 2007; status: completed.
02
Drugs
rotavirus vaccine, live, oral, pentavalent
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT00740935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00740935.